We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$569M
(+13%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
2.08%
Top 10 Holdings %
Top 10 Hldgs %
38.84%
Holding
3,762
New
251
Increased
1,450
Reduced
1,277
Closed
224
Avg Time Held Equity + Options
4.7
years
Top 10 Avg Time Held Equity + Options
2.9
years
Top 20 Avg Time Held Equity + Options
3.8
years
Avg Time Held Equity only
4.7
years
Top 10 Avg Time Held Equity only
2.9
years
Top 20 Avg Time Held Equity only
3.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$18.4M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$9.77M |
| 3 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$5.48M |
| 4 |
Microsoft
MSFT
|
+$4.93M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$4.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corcept Therapeutics
CORT
|
+$7.34M |
| 2 |
Starbucks
SBUX
|
+$4.7M |
| 3 |
iShares California Muni Bond ETF
CMF
|
+$3.3M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.63M |
| 5 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$1.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.71% |
| 2 | Technology | 17.21% |
| 3 | Healthcare | 9.68% |
| 4 | Financials | 7.2% |
| 5 | Communication Services | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
326
Constellation Brands
STZ
$21.6B
| $1.48M | 0.03% |
9,123
-2,361
| -21% | -$423K |
2016 Q4
34 quarters
|
|
327
Avantis US Large Cap Value ETF
AVLV
$21.9B
| $1.48M | 0.03% |
21,740
+14,753
| +211% | +$950K |
2025 Q1
1 quarter
|
|
328
Novartis
NVS
$279B
| $1.47M | 0.03% |
12,125
-706
| -6% | -$79.6K |
2016 Q4
34 quarters
|
|
329
PIMCO Municipal Income Fund II
PML
$430M
| $1.46M | 0.03% |
196,093
-1,000
| -0.5% | -$7.54K |
2024 Q2
4 quarters
|
|
330
Invesco Large Cap Growth ETF
PWB
$2.64B
| $1.45M | 0.03% |
12,330
| – | – |
2019 Q1
25 quarters
|
|
331
Enterprise Products Partners
EPD
$77.3B
| $1.45M | 0.03% |
46,686
-340
| -0.7% | -$10.6K |
2016 Q4
34 quarters
|
|
332
CME Group
CME
$103B
| $1.44M | 0.03% |
5,239
+303
| +6% | +$82.4K |
2016 Q4
34 quarters
|
|
333
iShares Short-Term National Muni Bond ETF
SUB
$12.3B
| $1.44M | 0.03% |
13,503
+5,900
| +78% | +$623K |
2021 Q1
17 quarters
|
|
334
DuPont de Nemours
DD
$17.4B
| $1.42M | 0.03% |
16,463
+475
| +3% | +$39.5K |
2016 Q4
34 quarters
|
|
335
PIMCO Corporate & Income Opportunity Fund
PTY
$2.35B
| $1.41M | 0.03% |
101,430
+385
| +0.4% | +$5.25K |
2022 Q1
13 quarters
|
|
336
Marathon Petroleum
MPC
$136B
| $1.41M | 0.03% |
8,470
+914
| +12% | +$137K |
2016 Q4
34 quarters
|
|
337
Mercado Libre
MELI
$93.2B
| $1.39M | 0.03% |
532
+333
| +167% | +$778K |
2019 Q2
24 quarters
|
|
338
State Street SPDR S&P International Dividend ETF
DWX
$510M
| $1.38M | 0.03% |
32,834
+101
| +0.3% | +$4.12K |
2016 Q4
34 quarters
|
|
339
Idexx Laboratories
IDXX
$41.7B
| $1.38M | 0.03% |
2,569
-39
| -1% | -$18.6K |
2016 Q4
34 quarters
|
|
340
iShares Core High Dividend ETF
HDV
$15.3B
| $1.37M | 0.03% |
58,330
-1,815
| -3% | -$41.8K |
2016 Q4
34 quarters
|
|
341
Bristol-Myers Squibb
BMY
$121B
| $1.36M | 0.03% |
29,333
-5,989
| -17% | -$294K |
2016 Q4
34 quarters
|
|
342
General Dynamics
GD
$90.5B
| $1.36M | 0.03% |
4,653
-117
| -2% | -$32.2K |
2016 Q4
34 quarters
|
|
343
Vanguard Communication Services ETF
VOX
$6.03B
| $1.36M | 0.03% |
7,927
+500
| +7% | +$76.9K |
2018 Q3
27 quarters
|
|
344
DoorDash
DASH
$79.7B
| $1.35M | 0.03% |
5,487
+876
| +19% | +$176K |
2022 Q2
12 quarters
|
|
345
iShares Core S&P US Growth ETF
IUSG
$34B
| $1.35M | 0.03% |
8,948
-230
| -3% | -$31.2K |
2016 Q4
34 quarters
|
|
346
Trane Technologies
TT
$104B
| $1.34M | 0.03% |
3,056
+120
| +4% | +$47.3K |
2016 Q4
34 quarters
|
|
347
Allstate
ALL
$59.7B
| $1.32M | 0.03% |
6,553
+57
| +0.9% | +$11.4K |
2016 Q4
34 quarters
|
|
348
Intercontinental Exchange
ICE
$87.1B
| $1.32M | 0.03% |
7,187
+231
| +3% | +$39.7K |
2016 Q4
34 quarters
|
|
349
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.55B
| $1.32M | 0.03% |
14,269
+377
| +3% | +$34.3K |
2016 Q4
34 quarters
|
|
350
Arthur J. Gallagher & Co
AJG
$60.8B
| $1.31M | 0.03% |
4,083
-164
| -4% | -$54.1K |
2016 Q4
34 quarters
|
|
Similar funds
Parallel Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Parallel Advisors's Q2 2025 filing shows 251 new, 1,450 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 47% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
- Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
- Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
- Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
- Parallel Advisors opened 251 new positions and closed 224 in Q2 2025.
- Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.
Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.